Sugi Predict

Sugi Predict / Compounds / SCHEMBL6607725

SCHEMBL6607725

SCHEMBL6607725

N#CC1(c2ccc([N+](=O)[O-])cc2Br)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VCAM1 P19320 2/20 0.40
▸ GAA P10253 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ LMNA P02545 3/20 0.38
▸ EGFR P00533 1/20 0.38
▸ CYP3A4 P08684 3/20 0.37
▸ TDP1 Q9NUW8 3/20 0.37
▸ NQO2 P16083 1/20 0.36
▸ TDP2 O95551 1/20 0.36
▸ SNCA P37840 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ TSHR P16473 2/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TLR9 Q9NR96 1/20 0.35
▸ ADRA2A P08913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30468432 1.00 VCAM1 (0.40) VCAM1GAAALDH1A1LMNAEGFR
SCHEMBL1769332 0.83 ALDH1A1 (0.45) VCAM1ALDH1A1LMNAEGFRCYP3A4
SCHEMBL31571876 0.83 ALDH1A1 (0.45) VCAM1ALDH1A1LMNAEGFRCYP3A4
SCHEMBL6612111 0.82 ALDH1A1 (0.50) VCAM1GAAALDH1A1LMNAEGFR
SCHEMBL19742444 0.81 VCAM1 (0.37) VCAM1GAAALDH1A1LMNAEGFR
SCHEMBL30279948 0.81 VCAM1 (0.37) VCAM1GAAALDH1A1LMNAEGFR
SCHEMBL19461720 0.78 PDE7A (0.41) VCAM1ALDH1A1LMNAEGFRPOLB
SCHEMBL29051804 0.76 GAA (0.45) GAAALDH1A1LMNACYP3A4TDP1
SCHEMBL30279902 0.75 ALDH1A1 (0.35) VCAM1GAAALDH1A1LMNAEGFR
SCHEMBL19742431 0.75 ALDH1A1 (0.35) VCAM1GAAALDH1A1LMNAEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054368-A1 COMPOUNDS, COMPOSITIONS, AND METHODS NICO THERAPEUTICS, INC. (US) 2025-03-13 — — WO disclosed
CN-116332910-A 2-aminopyrimidine derivatives as kinase inhibitors, preparation and use thereof 江苏威凯尔医药科技有限公司 2023-06-27 — — CN disclosed
EP-1448536-A1 CYCLOPROPYL-CONTAINING OXAZOLIDINONE ANTIBIOTICS AND DERIVATIVES THEREOF Merck & Co., Inc. (US) 2004-08-25 — — EP disclosed
US-6686363-B2 EFFECTIVE AGAINST MULTI-RESISTANT BACTERIA KYORIN PHARMACEUTICAL CO., LTD. (JP) 2004-02-03 — — US disclosed
US-20030225107-A1 CYCLOPROPYL CONTAINING OXAZOLIDINONE ANTIBIOTICS AND DERIVATIVES THEREOF MERCK SHARP & DOHME CORP. 2003-12-04 — — US disclosed
WO-2003048136-A1 CYCLOPROPYL HEXANE CONTAINING OXAZOLIDINONE ANTIBIOTICS AND DERIVATIVES THEREOF MERCK & CO., INC. (US) 2003-06-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225107-A1 CYCLOPROPYL CONTAINING OXAZOLIDINONE ANTIBIOTICS AND DERIVATIVES THEREOF ALAD, OXA1L, ECI1 VCAM1 3606/4885GAA 1003/4885ALDH1A1 824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.